Home » Regions » Global News » TFS, SCIderm partner for global dermatology trials

TFS, SCIderm partner for global dermatology trials

Wednesday, October 29, 2014

TFS International (TFS) and SCIderm have entered into a strategic partnership agreement to combine resources and scientific expertise within dermatology development.

The increasing R&D focus in dermatology and the need for well-executed global clinical trials has brought the two companies together to combine scientific and regulatory experience, relations with dermatology sites and global reach. TFS and SCIderm will jointly offer global and therapeutically aligned development services for life science companies with R&D in dermatology.

The partnership will target those dermatology companies in need of high level scientific and regulatory advice, access to dermatology investigators and managing the logistics and nuances associated with the conduct of larger multinational dermatology trials across Europe and North America.

TFS and SCIderm have been collaborating since 2011 in a variety of dermatological clinical trials and have established a proven working process, operational harmonization and a senior executive governance structure. The strategic partnership provides a reach of 200 investigational sites and access to more than 180,000 dermatological patients in Europe and North America. 

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!